IRCT20200317046797N2招募中3 期
Effect of Fingolimod for treatment of COVID-19-induced cytokine storm
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Moderate to severe 2019-nCoV-infected
- •18 Years to 80 Years
- •Patients or authorized family members volunteered to participate in this study and signed informed consent
- •Both genders
排除标准
- •Patient with elevated liver enzymes (3 times)
- •Patients who are participating in other drug clinical trials
- •Patients with active pulmonary tuberculosis
- •Patients with definite bacterial and fungal infections
- •Pregnant or lactating women
- •Patient with active thrombotic event
研究者
相似试验
撤回
2 期
Fingolimod in COVID-19Coronavirus Disease (COVID-19)NCT04280588First Affiliated Hospital of Fujian Medical University
已完成
3 期
Effect of interfron in the treatment of covidCovid pneumonia.Coronavirus as the cause of diseaseB97.2IRCT20230930059562N1Imam hossein hospital80
招募中
2 期
ANIF1 effect on COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20190727044343N3Mazandaran University of Medical Sceinces60
已完成
不适用
Evaluating the efficacy and side effects fingolimod in 3 -year follow-up of patients with recurrent forms of multiple sclerosisIRCT201705108323N15Vice chancellor for research, Kermanshah University of Medical Sciences50
招募中
2 期
Effect of Fingolimod in Multiple SclerosisMultiple sclerosisMultiple Sclerosis.IRCT20180204038608N1Tabriz University of Medical Sciences30